Table 2.
No significant differences between parameters values of patients in the test and control groups before the trial (results represented as mean ± SD values).
| Parameter |
Control mean ± SD |
LF mean ± SD |
|---|---|---|
| BUN (mg/dL) | 17.5 ± 8.04 | 16.23 ± 5.55 |
| Serum creatinine (mg/dL) | 1.05 ± 0.47 | 0.996 ± 0.524 |
| AST (IU/L) | 33.25 ± 18.4 | 40.59 ± 19.07 |
| ALT (IU/L) | 30.1 ± 16.19 | 37.46 ± 27.79 |
| Serum LF (ng/mL) | 0.186 ± 0.039 | 0.13 ± 0.018 |
| Serum GST enzyme (ng/mL) | 0.729 ± 0.073 | 0.679 ± 0.076 |
| INF-γ (pg/mL) | 32.36 ± 4.76 | 32.33 ± 4.65 |
| WBCs (∗103 cell/µL) | 7.55 ± 1.65 | 6.12 ± 1.97 |
| Platelet (∗103/mm3) | 217.2 ± 88.76 | 207.6 ± 69.84 |
| CEA (ng/mL) | 16.07 ± 17.37 | 30.16 ± 50.06 |
| RBCs (∗106/µL) | 4.3 ± 0.41 | 4.4 ± 0.63 |
| Neutrophil (%) | 46.86 ± 7.21 | 45.46 ± 7.37 |
| Hb (g/dL) | 11.1 ± 2.1 | 11.09 ± 1.67 |
Note: *significant difference P ≤ 0.05.